A Singapore study of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis (1).
D000328:Adult; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage*; D012293:Rifampin / Q000008:administration & dosage* / Q000009:adverse effects; D012846:Singapore; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D007538:Isoniazid; D012293:Rifampin